Justice Department Moves FDA-Approved Marijuana to Schedule III, Expanding Research Under Federal Oversight
· Texas Border Business
In accordance with President Trump’s December 18, 2025, Executive Order on Increasing Medical Marijuana and Cannabidiol Research, the Justice Department and the Drug Enforcement Administration (DEA) announced the issuance of an order immediately placing both FDA-approved products containing marijuana and marijuana products regulated by a state medical marijuana license in Schedule III of the Controlled Substances Act, The post Justice Department Moves FDA-Approved Marijuana to Schedule III, Expanding Research Under Federal Oversight appeared first on Texas Border Business.